Retinal Diseases
Information
- Disease name
- Retinal Diseases
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00481546 | Active, not recruiting | Phase 1 | Phase I Trial of Gene Vector to Patients With Retinal Disease Due to RPE65 Mutations | July 2007 | June 2026 |
| NCT06071546 | Active, not recruiting | N/A | Clinical Investigation of a New Version of MAIA Microperimeter on Healthy Subjects and Patients With Retinal Pathology | October 17, 2023 | September 17, 2024 |
| NCT00422721 | Completed | N/A | Genetic Study of Patients Suffering From Congenital Amaurosis of Leber or From an Early Severe Retinal Dystrophy | April 2007 | |
| NCT00437593 | Completed | N/A | UHR-OCT and HD-OCT for Preretinal Membranes: ICG Versus Membrane Blue | September 2005 | May 2008 |
| NCT00812760 | Completed | Phase 4 | Effect of Levodopa on Human Multifocal Electroretinogram | October 2001 | October 2003 |
| NCT01016873 | Completed | Phase 2 | INTREPID - IRay Plus Anti-VEGF Treatment For Patients With Wet AMD | November 2009 | April 2014 |
| NCT01205035 | Completed | Phase 2 | High-Dose Lucentis (Ranibizumab 2.0mg) for the Treatment of Nonproliferative Idiopathic Parafoveal Telangiectasia | October 2010 | October 2012 |
| NCT01399515 | Completed | Phase 2 | Efficacy and Safety of Oral Valproic Acid for Retinitis Pigmentosa | March 2011 | November 2015 |
| NCT00001668 | Completed | Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors | April 1997 | April 2000 | |
| NCT01746563 | Completed | Phase 1/Phase 2 | Intravitreal Ranibizumab Combined With Panretinal Photocoagulation in Patients With Proliferative Diabetic Retinopathy | May 2011 | August 2012 |
| NCT01790958 | Completed | Microcurrent Stimulation to Treat Macular Degeneration | June 2012 | December 2012 | |
| NCT01792154 | Completed | Measuring Corneal Cells With Specular Microscopy | August 2012 | November 2012 | |
| NCT02157077 | Completed | Phase 3 | Aflibercept After Ranibizumab in Exudative Age-related Macular Degeneration | December 2013 | December 2015 |
| NCT02196584 | Completed | Clinical Evaluation of the RAVI-Guide | August 2014 | June 2016 | |
| NCT02543229 | Completed | Phase 1 | Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD | July 2015 | September 2017 |
| NCT02582164 | Completed | N/A | Long-Working Distance OCT for Children | June 2015 | July 1, 2018 |
| NCT02646670 | Completed | Phase 4 | Efficacy of Ranibizumab Therapy With Aflibercept in Patients With Diabetic Macular Edema | July 2015 | November 2015 |
| NCT02828215 | Completed | Advanced OCT and Adaptive Optics Imaging in Retinal Disease (The ACAD Study) | July 1, 2015 | June 6, 2020 | |
| NCT02946879 | Completed | Long-Term Follow-Up Gene Therapy Study for Leber Congenital Amaurosis OPTIRPE65 (Retinal Dystrophy Associated With Defects in RPE65) | November 2016 | July 2023 | |
| NCT03954626 | Completed | Phase 3 | Study to Collect Safety and ECG Data on Brolucizumab 6 mg Intravitreal Treatment in Patients With Wet AMD | June 7, 2019 | July 31, 2019 |
| NCT04678375 | Completed | Artificial Intelligence for Detecting Retinal Diseases | June 1, 2018 | October 1, 2020 | |
| NCT04902170 | Completed | N/A | Long-shaft Vitrectomy Probe in Highly Myopic Eyes | July 22, 2021 | February 7, 2023 |
| NCT04919473 | Completed | Phase 1/Phase 2 | Dose-Escalation Study to Evaluate the Safety and Tolerability of Intravitreal vMCO-I in Patients With Advanced Retinitis Pigmentosa | October 23, 2019 | October 31, 2020 |
| NCT04945772 | Completed | Phase 2 | Efficacy and Safety of MCO-010 Optogenetic Therapy in Adults With Retinitis Pigmentosa [RESTORE] | July 13, 2021 | January 18, 2024 |
| NCT00000131 | Completed | Phase 3 | Central Vein Occlusion Study (CVOS) | August 1988 | February 1994 |
| NCT01404247 | Completed | Phase 1 | Spectral Domain Optical Coherence Tomography Imaging of the Eyes of Neonates | January 2011 | December 2015 |
| NCT06162585 | Enrolling by invitation | Non-Interventional Long Term Follow-up Study of Participants Previously Enrolled in the RESTORE Study | December 8, 2023 | September 2027 | |
| NCT06011798 | Recruiting | Phase 2 | Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE) | August 23, 2023 | June 2025 |
| NCT05724641 | Recruiting | N/A | Arterial Spin Labeling MRI for Assessing Blood Perfusion in the Human Eye Repeatability Study and Clinical Application | January 10, 2023 | June 30, 2026 |
| NCT04968756 | Recruiting | N/A | Evaluating the Safety of the SPECTRALIS CENTAURUS Device | September 9, 2021 | December 2025 |
| NCT05283941 | Recruiting | N/A | Pistachios and Neural Macular Pigment | June 10, 2022 | November 30, 2023 |
| NCT05836194 | Recruiting | Evaluation of Diabetic Retinopathy Using Ultra-Widefield Fundus Images Compared With Two-Field Fundus Images | February 1, 2023 | June 30, 2024 | |
| NCT05981950 | Recruiting | Real-world of AI in Diagnosing Retinal Diseases | August 1, 2023 | August 1, 2029 | |
| NCT02423213 | Recruiting | DISCOVER Study: Microscope-integrated Intraoperative OCT Study | January 2014 | January 2025 | |
| NCT01225146 | Terminated | Phase 1 | Study of 2.0 mg Ranibizumab in Subjects With Ischemic Central Retinal Vein Occlusion (RAVE2) | October 2010 | August 2012 |
| NCT01551771 | Terminated | Phase 1 | GW824575 First Time in Human | February 1, 2012 | April 12, 2012 |
| NCT02348359 | Terminated | Phase 2 | X-82 to Treat Age-related Macular Degeneration | March 16, 2015 | January 12, 2018 |
| NCT04592068 | Unknown status | AI Classifies Multi-Retinal Diseases | November 1, 2020 | December 1, 2021 | |
| NCT01217762 | Unknown status | Phase 1 | Safety & Tolerability of the IRay System in Subjects With Exudative Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD) | July 2008 | October 2014 |
| NCT04289064 | Unknown status | Artificial Intelligence System for Assessing Image Quality of Fundus Images and Its Effects on Diagnosis | February 1, 2020 | July 1, 2020 | |
| NCT01521065 | Unknown status | Phase 2 | An Open-label Study to Evaluate the Clinical and Economic Benefits of I-Ray in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration | September 2012 | October 2016 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D012164